期刊文献+

他汀类药物对急性心肌梗死患者肾功能的影响

Effect of statins on renal function in patients with acute myocardial infarction
下载PDF
导出
摘要 目的回顾性分析阿托伐他汀、辛伐他汀、氟伐他汀对急性心肌梗死患者肾功能的作用。方法选择105例急性心肌梗死患者,其中服用阿托伐他汀(A组)27例、辛伐他汀(B组)26例、氟伐他汀(C组)26例,未服用他汀类药物(对照组)26例。观察各组患者在治疗2周前后总胆固醇(TC)、低密度脂蛋白C(LDL-C)、肾小球滤过率(GFR)的变化值及之间的相关性。结果A、B、C三组患者经治疗后TC、LDL-C、GFR均较治疗前有所改善,并且与对照组比较有统计学差异(P〈0.05),其中TC、LDL-C改善水平与GFR改善有相关性。结论阿托伐他汀、辛伐他汀、氟伐他汀对急性心肌梗死患者具有肾保护作用,该作用与其降脂作用有一定相关性。 Objective To analyze the effects of atorvastatin, simvastatin and fluvastatin on renal function in patients with acute myocardial infarction. Methods 105 cases of acute myocardial infarction were randomly divided into atorvastatin group (27 cases), simvastatin group (26 cases), fluvastatin group(26 cases) and control group (26 cases). The correlation among total cholesterol(TC),low density lipoprotein C (LDL-C), glomerular filtration rate(GFR) was analyzed during two weeks. Results The TC, LDL-C and GFR in treatment groups after treatment were statistically lower than before (P〈 0. 05). There was correlation between TC and LDL-C with GFR. Conclusions Atorvastatin, simvastatin and fluvastatin protect the renal function in patients with acute myocardial infarction,which is related with their lipid-lowing effects.
出处 《临床肾脏病杂志》 2010年第9期400-403,共4页 Journal Of Clinical Nephrology
关键词 心肌梗死 胆固醇 肾小球滤过率 治疗 Myocardial Infarction Cholesterol Glomerular Filtration Rate Therapy
  • 相关文献

参考文献11

  • 1Anavekar NS, Mcmurray JJ, Velazquez EJ, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med,2004,351:1285-1295.
  • 2Han KH,Ryu J, Hong KH, et al. HMG-CoA reductase inhibition reduces monoeyte CC chemokine receptor 2 expression and monocyte chemoattraetant protein-1-mediated monocyte recruitment in vivo. Circulation, 2005,111 : 1439d 447.
  • 3Myers GL, Miller WG, Coresh J, et al. Recommendations for improving serum creatinine measurement:A report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem, 2006,52 : 5-18.
  • 4Lee KY,DAcquisto F, Hayden MS, et al. PDK1 nucleates T cell receptor-induced signaling complex for NF-kappaB activation. Science, 2005,308 : 114-118.
  • 5Huskey J, Lindenfeld J, Cook T, et al. Effect of simvastatin on kidney function loss in patients with coronary heart disease:Find ings from the Scandinavian Simvastatin Survival Study (4S). Atherosclerosis, 2009,205 : 202-206.
  • 6Athyros VG,Mikhailidis DP, Papageorgiou AA, et al. The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study. J Clin Pathol, 2004,57: 728-734.
  • 7Hertig A,Gangadhar T, Kalluri R. Renal studies provide an insight into cardiac extracellular matrix remodeling during health and disease. J Mol Cell Cardiol, 2010,48 . 497-503.
  • 8Buemi M,Senatore M,Corica F, et al. Statins and progressive renal disease. Med Res Rev, 2002,22 : 76-84.
  • 9Scheuer H, Gwinner W, Hohbaeh J, et al. Oxidant stress in hyperlipidemia-induced renal damage. Am J Physiol Renal Physiol, 2000,278 : 63-74.
  • 10Russi G, Furci L, Leonelli M, et al. Lipoprotein glomerulopathy treated with LDL-apheresis(Heparin-induced Extracorporeal Lipoprotein Precipitation system) : A case report. J Med Case Reports,2009,3:9311.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部